Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

MTG8 proto-oncoprotein interacts with the regulatory subunit of type II cyclic AMP-dependent protein kinase in lymphocytes

Abstract

AML1-MTG8 chimeric oncogene is generated in acute myelogenous leukemia with t(8;21), and seems to be responsible for the pathogenesis of the disease. However, the role of MTG8 is ambiguous. Here we found that MTG8 interacted with the regulatory subunit of type II cyclic AMP-dependent protein kinase (PKA RIIα). The binding site of MTG8 was NHR3 domain, and that of RIIα was the N-terminus for interacting with PKA anchoring proteins (AKAPs). NHR3 contains a putative α-amphipathic helix which is characteristic in binding of AKAPs with RII. Indirect immunofluorescence microscopy showed that MTG8 and RIIα were overlapped at the centrosome-Golgi area in lymphocytes. These findings suggest that MTG8 may function as an AKAP at the centrosome-Golgi area in lymphocytes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Calabi F, Cilli V . 1998 Genomics 52: 332–341

  • Carr DW, Stofko-Hahn RE, Fraser ID, Bishop SM, Acott TS, Brennan RG, Scott JD . 1991 J. Biol. Chem. 266: 14188–14192

  • Colledge M, Scott JD . 1999 Trends Cell Biol. 9: 216–221

  • Davis JN, Williams BJ, Herron JT, Galiano FJ, Meyers S . 1999 Oncogene 18: 1375–1383

  • Downing JR . 1999 Br. J. Haematol. 106: 296–308

  • Erickson P, Gao J, Chang KS, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo J, Rowley J, Drabkin H . 1992 Blood 80: 1825–1831

  • Erickson PF, Dessev G, Lasher RS, Philips G, Robinson M, Drabkin HA . 1996 Blood 88: 1813–1823

  • Faux MC, Scott JD . 1996 Cell 85: 9–12

  • Feinstein PG, Kornfeld K, Hogness DS, Mann RS . 1995 Genetics 140: 573–586

  • Fracchiolla NS, Colombo G, Finelli P, Maiolo AT, Neri A . 1998 Blood 92: 3481–3484

  • Frank RC, Sun X, Berguido FJ, Jakubowiak A, Nimer SD . 1999 Oncogene 18: 1701–1710

  • Friedman AD . 1999 Leukemia 13: 1932–1942

  • Gamou T, Kitamura E, Hosoda F, Shimizu K, Shinohara K, Hayashi Y, Nagase T, Yokoyama Y, Ohki M . 1998 Blood 91: 4028–4037

  • Gelmetti V, Zhang J, Fanelli M, Minucci S, Pelicci PG, Lazar MA . 1998 Mol. Cell. Biol. 18: 7185–7191

  • Gross CT, McGinnis W . 1996 EMBO J. 15: 1961–1970

  • Ito Y . 1999 Genes Cells 4: 685–696

  • Keryer G, Skalhegg BS, Landmark BF, Hansson V, Jahnsen T, Tasken K . 1999 Exp. Cell Res. 249: 131–146

  • Kitabayashi I, Ida K, Morohoshi F, Yokoyama A, Mitsuhashi N, Shimizu K, Nomura N, Hayashi Y, Ohki M . 1998 Mol. Cell. Biol. 18: 846–858

  • Klauck TM, Faux MC, Labudda K, Langeberg LK, Jaken S, Scott JD . 1996 Science 271: 1589–1592

  • Komori A, Sueoka E, Fujiki H, Ishii M, Kozu T . 1999 Jpn. J. Cancer Res. 90: 60–68

  • Kozu T, Miyoshi H, Shimizu K, Maseki N, Kaneko Y, Asou H, Kamada N, Ohki M . 1993 Blood 82: 1270–1276

  • Le XF, Claxton D, Kornblau S, Fan YH, Mu ZM, Chang KS . 1998 Eur. J. Haematol. 60: 217–225

  • Liu P, Tarle SA, Hajra A, Claxton DF, Marlton P, Freedman M, Siciliano MJ, Collins FS . 1993 Science 261: 1041–1044

  • Look AT . 1997 Science 278: 1059–1064

  • Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Rosenfeld MG, Glass C, Seto E, Hiebert SW . 1998 Mol. Cell. Biol. 18: 7176–7184

  • McNeil S, Zeng C, Harrington KS, Hiebert S, Lian JB, Stein JL, van Wijnen AJ, Stein GS . 1999 Proc. Natl. Acad. Sci. USA 96: 14882–14887

  • Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, Yazaki Y, Ohki M, Hirai H . 1994 EMBO J. 13: 504–510

  • Miyoshi H, Kozu T, Shimizu K, Enomoto K, Maseki N, Kaneko Y, Kamada N, Ohki M . 1993 EMBO J. 12: 2715–2721

  • Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M . 1991 Proc. Natl. Acad. Sci. USA 88: 10431–10434

  • Newlon MG, Roy M, Morikis D, Hausken ZE, Coghlan V, Scott JD, Jennings PA . 1999 Nat. Struct. Biol. 6: 222–227

  • Nigg EA, Schafer G, Hilz H, Eppenberger HM . 1985 Cell 41: 1039–1051

  • Nisson PE, Watkins PC, Sacchi N . 1992 Cancer Genet. Cytogenet. 63: 81–88

  • Ogawa E, Maruyama M, Kagoshima H, Inuzuka M, Lu J, Satake M, Shigesada K, Ito Y . 1993 Proc. Natl. Acad. Sci. USA 90: 6859–6863

  • Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR . 1996 Cell 84: 321–330

  • Osato M, Asou N, Abdalla E, Hoshino K, Yamasaki H, Okubo T, Suzushima H, Takatsuki K, Kanno T, Shigesada K, Ito Y . 1999 Blood 93: 1817–1824

  • Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA . 1995 Blood 85: 3662–3670

  • Sacchi N, Tamanini F, Willemsen R, Denis-Donini S, Campiglio S, Hoogeveen AT . 1998 Oncogene 16: 2609–2615

  • Schmidt PH, Dransfield DT, Claudio JO, Hawley RG, Trotter KW, Milgram SL, Goldenring JR . 1999 J. Biol. Chem. 274: 3055–3066

  • Skalhegg BS, Tasken K, Hansson V, Huitfeldt HS, Jahnsen T, Lea T . 1994 Science 263: 84–87

  • Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, Kufrin D, Ratajczak J, Resende IC, Haworth C, Hock R, Loh M, Felix C, Roy DC, Busque L, Kurnit D, Willman C, Gewirtz AM, Speck NA, Bushweller JH, Li FP, Gardiner K, Poncz M, Maris JM, Gilliland DG . 1999 Nat. Genet. 23: 166–175

  • Sueoka E, Sueoka N, Okabe S, Komori A, Suganuma M, Kozu T, Fujiki H . 1998 Br. J. Haematol. 101: 737–742

  • Takahashi M, Shibata H, Shimakawa M, Miyamoto M, Mukai H, Ono Y . 1999 J. Biol. Chem. 274: 17267–17274

  • Tasken K, Skalhegg BS, Tasken KA, Solberg R, Knutsen HK, Levy FO, Sandberg M, Orstavik S, Larsen T, Johansen AK, Vang T, Schrader HP, Reinton NT, Torgersen KM, Hansson V, Jahnsen T . 1997 Adv. Second Messenger Phosphoprotein Res. 31: 191–204

  • Wang J, Hoshino T, Redner RL, Kajigaya S, Liu JM . 1998 Proc. Natl. Acad. Sci. USA 95: 10860–10865

  • Wang J, Wang M, Liu JM . 1997 Cancer Res. 57: 2951–2955

  • Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA . 1996 Proc. Natl. Acad. Sci. USA 93: 3444–3449

  • Witczak O, Skalhegg BS, Keryer G, Bornens M, Tasken K, Jahnsen T, Orstavik S . 1999 EMBO J. 18: 1858–1868

  • Wolford JK, Prochazka M . 1998 Gene 212: 103–109

Download references

Acknowledgements

We would like to express our thanks to Professor Kinji Inoue (Laboratory of Cell Biology, Department of Regulation Biology, Faculty of Science, Saitama University, Japan) for advice on confocal microscopy. This work was supported in part by Grants-in-Aid for Science from the Ministry of Education, Science, Sports, and Culture of Japan, Grant of Clinical Research Foundation (2000) as well as Cutting Edge Fundamental Research from Saitama Prefecture; and grants from the Organization for Pharmaceutical Safety and Research (OPSR), and from the Kawano Memorial Foundation for Promotion of Pediatrics, Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tomoko Kozu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fukuyama, T., Sueoka, E., Sugio, Y. et al. MTG8 proto-oncoprotein interacts with the regulatory subunit of type II cyclic AMP-dependent protein kinase in lymphocytes. Oncogene 20, 6225–6232 (2001). https://doi.org/10.1038/sj.onc.1204794

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204794

Keywords

This article is cited by

Search

Quick links